Tags (7) : oncology
Arcera–Fosun Pharma MoU to Boost Global Life Sciences & Neuroscience Innovation
04/28/2026 | Companies
Abu Dhabi,
Alzheimer’s disease,
Arcera Life Sciences,
biologics,
biotechnology,
biotechnology incubation,
cardiometabolic diseases,
cell therapy,
China,
drug development,
emerging markets,
Fosun Pharma,
gene therapy,
global healthcare,
healthcare infrastructure,
innovation,
international collaboration,
joint ventures,
licensing,
life sciences,
market access,
memorandum of understanding,
Middle East healthcare,
MoU,
neurodegenerative diseases,
neuroscience,
oncology,
pharmaceutical industry,
R&D,
radiopharmaceuticals,
rare diseases,
research and development,
siRNA therapies,
small molecules,
strategic partnership,
UAE,
Vision 2030
Mabwell Advances 6MW5311 Bispecific Antibody for AML and Blood Cancers
04/16/2026 | Companies
6MW5311,
acute myeloid leukemia,
AML,
biopharmaceuticals,
biotechnology,
bispecific antibody,
cancer research,
CD3,
chronic myelomonocytic leukemia,
clinical trials,
CMML,
cytotoxicity,
drug development,
FDA,
hematologic malignancies,
immune synapse,
immunotherapy,
IND application,
LILRB4,
Mabwell,
MM,
multiple myeloma,
NMPA,
oncology,
preclinical studies,
stem cell transplantation,
steric hindrance,
T cell engager,
targeted therapy,
TCE technology,
tumor inhibition
Wesco VOLT 2025 Veteran Employee Scholarship Recipients Announced
05/30/2025 | Companies
2025 scholarship,
Adit Bhootra,
business analytics,
cancer research,
Christopher Bruno,
college scholarship,
computer engineering,
construction management,
education support,
electrical engineering,
engineering,
high school seniors,
law degree,
military families,
military service,
oncology,
Payton Moore,
Raul Alvarez,
scholarship program,
scholarship recipients,
student scholarships,
Syracuse University,
Tarleton State University,
The College of New Jersey,
trade school,
University of Wisconsin Madison,
Veteran Employee Scholarship,
Veterans Opportunity Liaison Team,
VOLT,
Wesco,
Wesco employees
Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025
05/29/2025 | Companies
American Society of Clinical Oncology,
ASCO,
cancer research,
cancer treatment,
CAR T-cell therapy,
clinical trials,
collaborative research,
EHA,
European Hematology Association,
GileadNews,
hematology,
innovative therapies,
investigational therapy,
Kite Pharma,
metastatic triple-negative breast cancer,
oncology,
Phase 2 results,
recurrent glioblastoma,
refractory multiple myeloma,
relapsed multiple myeloma
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com


Companies